OnKure Therapeutics, Inc.
OKUR • XNAS • Stock Fundamentals
OnKure Therapeutics, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Nicholas A. Saccomano, with a market cap of $171.7M.
Market Cap$171.7M
CEONicholas A. Saccomano
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
OnKure Therapeutics, Inc. FAQ
Common questions about OnKure Therapeutics, Inc.
OnKure Therapeutics, Inc. (OKUR) has a market capitalization of $171.7M and trades on XNAS.